Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Troglitazone for atherosclerosis in diabetes
NCT00116545Phase 3Completed
- Sponsor
- Parke-Davis
- Start
- Jan 1997
- Primary completion
- Apr 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of troglitazone in atherosclerosis, sponsored by Parke-Davis. Started Jan 1997; status: completed.
02
Drugs
troglitazone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00116545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116545.